FDA Investigator Courtney R Ingalsbe
Courtney R Ingalsbe has conducted inspections on 139 sites in 3 countries as of 15 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
139
Last Inspection Date:
15 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Japan,
Italy
FDA Investigators that have inspected at least one site in common with Courtney R Ingalsbe:
Aaron J Poloni,
Abram A Brown,
Alan R Albrecht,
Alison A Nicoli,
Amy F Anderson,
Amy L Mcintyre,
Ana M Placencia,
Anders W Evenson,
Andrea J Schmidt,
Anita Narula, PhD,
Anthony J Ladner,
Anthony L Loosbrock,
Anthony L Nicoli,
April L Brown,
April L Young,
Arnold C Shih,
Beatrix D Arevalo,
Beatrix D Hippe,
Becky L Bhan,
Benjamin W Anderson,
Billi Jom Johnson,
Bradley A Servais,
Carolyn A Warren,
Carolyn J Cook,
Catherine M Vanderhoef,
Charles R Cote, RIC,
Christina A Castineyra,
Christine L Williams,
Courtney R Tiegs,
Cristina E Mosquera,
Dacia E Quick,
Danielle M Didonna,
Darren D Holaday,
David B Wieneke,
Debbie K Giang,
Demetria L Lueneburg,
Denise L Burosh,
Dennis N Hoang,
Diana L Ayala,
Diana M Rand,
Diane T Kretschmer,
Diane T Reindl,
Dianna C Sonnenburg,
Doris Ruley,
Douglas J Snyder,
Douglas W Atkins,
Duc Minh H Nguyen,
Edith M Gonzalez,
Edward A Fabiano,
Edward M James,
Elizabeth P Mayer,
Emily E Markgraf,
Eric A Breselow,
Eric S Myskowski,
Fallon J Ryan,
Fannie M Harrell,
Felicia M Orlando,
Frank S Sedzielarz,
Garrett W Steiner,
Gina M Scholze,
Gloria J Baca, MS,
Grant M Ruis,
Gregory A Berg,
Gregory S Larson,
Gregory W Smith,
Heather Akleimola Hulbert,
Howard A Burmester,
Hung H Do, MS,
Isabel Y Espinosa,
Ivan E Reyes,
Jaclyn N Munsch,
Jacob W Reynolds,
Jake T Lane,
James A Beaulieu,
James K Ireland,
James P Stallings,
James R Montero,
Jane E Nelson,
Jeff M Uriarte,
Jeffry A Bernhardt,
Jennifer A Longie Vollom,
Jennifer A Robinson,
Jennifer Guttuso,
Jennifer R Mathern,
Jeremy L Tri,
Jesse P Romenesko,
Jessica I Newman,
Jessica L Barr,
Jill Herberg,
John A Daubenspeck,
John A Liu,
John E Emmert,
John P Hermann,
Jon C Polzine,
Jonathan G Gayechuway,
Joseph D Gong,
Joseph J Golden,
Julie Woodberry,
Justin A Boyd,
Karen M Labounty,
Karla J Youngberg,
Katherine A Clarke Girolamo,
Kathleen S Tormey,
Kathryn M Mogen,
Kathy Ac Girolamo,
Keith C Rindahl,
Kellie L Thommes, RN,
Kellie L Westerbuhr,
Kenneth A Libertoski,
Kevin L Torgerson,
Kevin Lee,
Kevin P Regan,
Kibily D Dembele,
Krista K Petersen,
Kristine J Mantaring,
Kristy E Zuroski,
Kyle J Mccracken,
Kyle Posterick,
Larisa E Pavlick,
Larry Gehring,
Lauren E Merz,
Lauren E Sanger,
Leonardm,
Lin Liu,
Linda M Cheny,
Linda V Weyer,
Ling Yu L Liu,
Lisa A Bowden,
M Edith Snyder,
Mada A Tautges,
Margaret M Lubbers Solberg,
Maria E Treadwell,
Marie A Fadden,
Marijo B Kambere, PhD,
Marissa S Henning,
Marissa S Steinhagen,
Matthew A Johnson,
Melanie C Voges,
Melissa D Kalik,
Melissa I Michurski,
Melissa I Stittsworth,
Michael J Chan,
Michele Perry Williams,
Miles D Foster,
Mohammed H Adam,
Monica E Murie,
Nancy E Byerly,
Nicholas Fragedakis,
Nicholas L Hunt,
Nicholas S Vasilakes,
Nicole C Victoria, PhD,
Ounchith J Phabmixay,
Paola E Lathrop,
Patrick J Campbell,
Paula J Wilkerson,
Phal K Chhun,
Ralph Jerndal,
Rebecca L Caulfield,
Rebecca L Keller,
Rebecca L Zamora,
Ricki A Chase,
Robert H Claflin,
Robert J Waldorf,
Ross J Grigsby,
Rostislav Servetnyk,
Ryan P Morgan,
Saied A Asbagh,
Sana A Elassar,
Sandra A Hughes,
Sandra D Wilson,
Sandra Sejdinovic,
Sarah A Palmer,
Scott A Golladay,
Scott T Panagiotis,
Secrist,
Seth A Abbott,
Sharon K Thoma, PharmD,
Sharon M Harold,
Shaun M Olson,
Sorana Black,
Soyinka S Eneng,
Stephanie A Jameson,
Susan M Matthias,
Susan M Miller,
Susanna N Choi,
Tara M Carolfi,
Tara M Humfeld,
Tenzin Jangchup,
Theresa C Klaman,
Thomas S Donaldson,
Tony T Yang,
Traci C Kelm,
Victoria L Palmer,
Wendy S Antonowsky,
William E Keer,
William P Fournier,
Zachary A Bogorad,
Zachary P Wachlarowicz
Courtney R Ingalsbe's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2019 | FDA 483 | West Duluth Distribution Company dba CHK Nutrition - Form 483, 2019-08-23 |
December, 2018 | FDA 483 | Upsher-Smith Laboratories, LLC - Form 483, 2018-12-19 |
July, 2016 | FDA 483 | ANI Pharmaceuticals, Inc. - Form 483, 2016-07-28 |
August, 2019 | EIR | West Duluth Distribution Company dba CHK Nutrition - EIR, 2019-08-23 |
March, 2017 | FDA 483 | Hillestad Pharmaceuticals USA - Form 483, 2017-03-03 |
November, 2021 | EIR | Chr-Hansen - Wausau - EIR, 2021-11-18 |
May, 2018 | EIR | thirty-two degrees, LLC - EIR, 2018-05-02 |
April, 2022 | FDA 483 | Perrigo Wisconsin, LLC - Form 483, 2022-04-14 |
January, 2019 | FDA 483 | LTS Therapy Systems, LLC - Form 483, 2019-01-31 |
December, 2018 | FDA 483 | Upsher-Smith Laboratories, LLC - Form 483, 2018-12-19 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more